Back
HFA Premium Access

Fluoropyrimidine chemotherapy and the risk of death and cardiovascular events in patients with gastrointestinal cancer: a cohort study

Session: How to improve prognosis in cardio-oncology
Topic: Cardio-Oncology
Speaker: Doctor A. Abiodun (London, GB)
Event: Heart Failure 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Aderonke Abiodun

Barts Health Trust, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

4 more presentations in this session

Cardiotoxicity in multiple myeloma patients in Hong Kong: a single-centre experience in the past decade

Speaker: Doctor M. Ho (Hong Kong, HK)

Access
Abstract
Slides
Video
Like
Thumbnail

The predictive value of routine troponin measurements in patients treated with immune checkpoint inhibitors

Speaker: Doctor M. Laufer-Perl (Tel Aviv, IL)

Access
Abstract
Slides
Video
Like
Thumbnail

Inherited cardiovascular disease mindset at cardio-oncology screening

Speaker: Doctor R. Lorca (Oviedo, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Soluble guanylate cyclase activator vericiguat prevents anthracycline-mediated cardiotoxicity and sarcopenia through NO-sGC-cGMP-NLRP3 pathway

Speaker: Doctor N. Maurea (Naples, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

How to improve prognosis in cardio-oncology

Speakers: Doctor A. Abiodun, Doctor M. Ho, Doctor M. Laufer-Perl, Doctor R. Lorca, Doctor N. Maurea
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources